BBOS
DEAD

Serial Number

79382010

Owner

COST-BRY PTY LTD

Filing Date

Sep 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BBOS Trademark

Serial Number: 79382010

BBOS is a trademark filed by COST-BRY PTY LTD on September 26, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

COST-BRY PTY LTD (4 trademarks)

Level 3, 21-24 North Terrace

Entity Type: 99

Trademark Details

Filing Date

September 26, 2023

Registration Date

Not Registered

Goods & Services

Advisory services relating to medical services; alternative medical services; providing medical services for charitable purposes; gastroenterology (medical services); medical diagnostic services (testing and analysis); advisory services relating to medical problems; advisory services relating to health; health assessment services; health care consultancy services (medical); none of the foregoing relating to bepotastine besilate ophthalmic solution or the treatment of ocular itching associated with allergic conjunctivitis (AC); all of the foregoing relating to microbiome based products and therapies and the treatment and prevention of disease by restoring gut microbial ecology

Biological research; bacteriological research; biotechnology testing; biochemistry research services; biotechnology research; biotechnological research; research relating to biotechnology; genetic research; medical research; preparation of reports relating to technical research; conducting statistical scientific studies; pharmaceutical research services; rental of research facilities; research and development of new products for others; research to develop new products; research relating to bacteriology; advisory services relating to technological research; technological research; provision of scientific information; advisory services relating to scientific research; medical research (scientific research for medical purposes); preparation of reports relating to scientific research; analysis of statistical data for scientific research; scientific research into the development of new products; scientific research relating to bacteriology; scientific research relating to biology; scientific research relating to genetics; providing information, including online, about scientific and technological services and research and design relating thereto; provision of information relating to scientific research; scientific research; laboratory analysis; laboratory services (scientific research or analysis); product analysis; scientific and technical analysis; none of the foregoing relating to bepotastine besilate ophthalmic solution or the treatment of ocular itching associated with allergic conjunctivitis (AC); all of the foregoing relating to microbiome based products and therapies and the treatment and prevention of disease by restoring gut microbial ecology

Biological agents (bacterial, fungal or other fungicides, weedkillers, herbicides, insecticides, parasiticides, pesticides); biological control agents; biological preparations for medical purposes; biological preparations for pharmaceutical purposes; biological preparations for use in biotechnology (medical); biological preparations for use in cell cultures (medical); biological products for medical use; biological substances for medical use; biological tissue cultures for medical purposes; reagents for use in biological processing (for medical purposes); bacteriological culture mediums; bacteriological cultures for medical and veterinary use; bacteriological preparations for medical and veterinary use; testing reagents for medical use in detecting allergenic substances; capsules for pharmaceutical purposes; pharmaceutical preparations in the form of tablets; medicines in tablet form; none of the foregoing relating to bepotastine besilate ophthalmic solution or the treatment of ocular itching associated with allergic conjunctivitis (AC); all of the foregoing relating to microbiome based products and therapies and the treatment and prevention of disease by restoring gut microbial ecology

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 22, 2026 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jan 7, 2026 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 7, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 12, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 25, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 25, 2025 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 7, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 7, 2025 ABN2
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Nov 14, 2024 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Jul 19, 2024 LIMG
REFUSAL PROCESSED BY IB
Jul 15, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 24, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jun 24, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 5, 2024 RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 5, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 17, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 24, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 31, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 27, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 26, 2023 REPR